Growing community of inventors

San Diego, CA, United States of America

Chengzhi Yu

Average Co-Inventor Count = 4.80

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Chengzhi YuBin Liu (4 patents)Chengzhi YuHang Cheng (4 patents)Chengzhi YuChenggang Zhang (4 patents)Chengzhi YuWeiyan Xiong (3 patents)Chengzhi YuPatrick Soon-Shiong (2 patents)Chengzhi YuPaul Weingarten (2 patents)Chengzhi YuNeil P Desai (1 patent)Chengzhi YuVuong Trieu (35 patents)Chengzhi YuChunlin Tao (2 patents)Chengzhi YuForrest Arp (2 patents)Chengzhi YuQinwei Wang (1 patent)Chengzhi YuChengzhi Yu (6 patents)Bin LiuBin Liu (157 patents)Hang ChengHang Cheng (6 patents)Chenggang ZhangChenggang Zhang (4 patents)Weiyan XiongWeiyan Xiong (4 patents)Patrick Soon-ShiongPatrick Soon-Shiong (447 patents)Paul WeingartenPaul Weingarten (10 patents)Neil P DesaiNeil P Desai (30 patents)Vuong TrieuVuong Trieu (35 patents)Chunlin TaoChunlin Tao (32 patents)Forrest ArpForrest Arp (3 patents)Qinwei WangQinwei Wang (5 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shengke Pharmaceuticals (jiangsu) Ltd. (3 from 3 patents)

2. Other (1 from 832,880 patents)

3. Nant Holdingsip, LLC (1 from 553 patents)

4. Nantbioscience, Inc. (1 from 9 patents)

5. Abraxis Bioscience, LLC (82 patents)


6 patents:

1. 12428423 - 1H-imidazo[4,5-h]quinazoline compound as protein kinase inhibitor

2. 11993604 - Substituted pyrazolo[4,3-H]quinazolines as protein kinase inhibitors

3. 11319323 - Substituted pyrazolo[4,3-H]quinazolines as protein kinase inhibitors

4. 11091485 - Imidazo[1',2′:1,6]pyrido[2,3-d]pyrimidine compound as protein kinase inhibitor

5. 10183013 - Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway

6. 9499539 - Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…